| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAZY | Common Stock | Options Exercise | $99.9K | +9K | +3.53% | $11.10 | 264K | Nov 16, 2021 | Direct | |
| transaction | LAZY | Common Stock | Sale | -$190K | -9K | -3.41% | $21.15 | 255K | Nov 16, 2021 | Direct | F1 |
| transaction | LAZY | Common Stock | Options Exercise | $9.3K | +838 | +0.33% | $11.10 | 256K | Nov 17, 2021 | Direct | |
| transaction | LAZY | Common Stock | Sale | -$17.7K | -838 | -0.33% | $21.13 | 255K | Nov 17, 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAZY | Employee Stock Option (right to buy) | Options Exercise | $0 | -9K | -0.86% | $0.00 | 1.04M | Nov 16, 2021 | Common Stock | 9K | $11.10 | Direct | F3, F4 |
| transaction | LAZY | Employee Stock Option (right to buy) | Options Exercise | $0 | -838 | -0.08% | $0.00 | 1.04M | Nov 17, 2021 | Common Stock | 838 | $11.10 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $21.10 to $21.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4 |
| F2 | This transaction was executed in multiple trades at prices ranging from $21.10 to $21.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4 |
| F3 | The option shall vest as follows and shall be exercisable only to the extent that it has vested: 30% of the option shall vest once the VWAP (defined below) is equal to or greater than $13.125 per share for at least thirty (30) out of thirty-five (35) consecutive trading days ("Specific Period"); an additional 30% of the option shall vest once the VWAP is equal to or greater than $17.50 per share for a Specific Period; an additional 30% of the option shall vest once the VWAP is equal to or greater than $21.875 per share for a Specific Period; and an additional 10% of the option shall vest once the VWAP is equal to or greater than $35 per share for a Specific Period; provided that the reporting person remains continuously employed by the company (and/or any of its subsidiaries) from the grant date through (and including) the relevant date of vesting. Any such VWAP shall be adjusted for share splits, extraordinary dividends, reorganizations, recapitalizations or similar events. |
| F4 | "VWAP" means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares are then listed or quoted on a national securities exchange, the daily volume weighted average price of the shares for such date (or the nearest preceding date) on the national securities exchange on which the shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)), (b) if the shares are not then listed or quoted for trading on any national securities exchange and if prices for the shares are then reported on the OTC Bulletin Board or in the "Pink Sheets" published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the shares so reported, or (c) in all other cases, the fair market value of the shares as determined in good faith by the committee. |